Pfizer Inc.
Cysteine engineered antibody drug conjugates

Last updated:

Abstract:

The invention relates to polypeptides, antibodies, and antigen-binding fragments thereof, that comprise an engineered cysteine for site-specific conjugation.

Status:
Grant
Type:

Utility

Filling date:

24 Sep 2018

Issue date:

21 Jun 2022